Nihong Lu

461 total citations
18 papers, 364 citations indexed

About

Nihong Lu is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Nihong Lu has authored 18 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Infectious Diseases. Recurrent topics in Nihong Lu's work include Cancer-related molecular mechanisms research (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Natural product bioactivities and synthesis (3 papers). Nihong Lu is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Natural product bioactivities and synthesis (3 papers). Nihong Lu collaborates with scholars based in China, Czechia and Thailand. Nihong Lu's co-authors include Ruiwei Guo, Xianmei Wang, Lixia Yang, Yan-Kun Shi, Ting Li, Zhengkun Li, Xiaoyuan Zhao, Wenjuan Wu, Tao Zhang and Yanni Yang and has published in prestigious journals such as Angewandte Chemie International Edition, Biochemical and Biophysical Research Communications and Journal of Hepatology.

In The Last Decade

Nihong Lu

16 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nihong Lu China 7 252 197 108 50 39 18 364
Ziqi Cheng China 10 178 0.7× 105 0.5× 81 0.8× 35 0.7× 26 0.7× 15 323
Xingruo Zeng China 11 301 1.2× 181 0.9× 50 0.5× 39 0.8× 35 0.9× 31 467
Hanqing Guo China 9 174 0.7× 96 0.5× 36 0.3× 72 1.4× 27 0.7× 17 320
Minyi Xu China 7 255 1.0× 196 1.0× 221 2.0× 43 0.9× 42 1.1× 8 450
Chen-Tsung Huang China 12 206 0.8× 82 0.4× 32 0.3× 40 0.8× 43 1.1× 31 333
Xiaopei Yan China 7 211 0.8× 60 0.3× 99 0.9× 21 0.4× 94 2.4× 10 321
Jiyuan Yang China 11 294 1.2× 188 1.0× 98 0.9× 24 0.5× 29 0.7× 26 477
Qing Ma China 12 280 1.1× 109 0.6× 38 0.4× 28 0.6× 28 0.7× 29 452
Zequn Niu China 13 227 0.9× 163 0.8× 42 0.4× 50 1.0× 41 1.1× 24 335
Yingjian Jiang China 9 163 0.6× 56 0.3× 88 0.8× 119 2.4× 42 1.1× 18 325

Countries citing papers authored by Nihong Lu

Since Specialization
Citations

This map shows the geographic impact of Nihong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nihong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nihong Lu more than expected).

Fields of papers citing papers by Nihong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nihong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nihong Lu. The network helps show where Nihong Lu may publish in the future.

Co-authorship network of co-authors of Nihong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Nihong Lu. A scholar is included among the top collaborators of Nihong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nihong Lu. Nihong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Xu, Suheng, Yong Ryoul Yang, Honglu Liu, et al.. (2025). Actein, a 9,19-Cyclobutane Triterpenoid from Cimicifuga spp., Ameliorates Atherosclerosis via ABCG1 and LXR Upregulation. Pharmacology. 111(1). 1–9.
2.
3.
Liu, Rui, et al.. (2023). Analgesic Buxus alkaloids with Enhanced Selectivity for the Low‐Voltage‐Gated Calcium Channel Cav3.2 over Cav3.1 through a New Binding Mode. Angewandte Chemie International Edition. 63(1). e202313461–e202313461. 2 indexed citations
4.
Li, Xiaofei, et al.. (2022). NOS2/miR-493-5p Signaling Regulates in the LPS-Induced Inflammatory Response in the RAW264.7 Cells. Biochemical Genetics. 61(3). 1097–1112. 2 indexed citations
5.
Du, Yingrong, Jun Liu, Jianpeng Gao, et al.. (2022). Effects of HIV-related worries on fertility motivation moderated by living children among couples living with HIV: A dyadic analysis. Frontiers in Psychology. 13. 1000100–1000100. 1 indexed citations
6.
Lu, Nihong, et al.. (2021). New triterpenes from Cimicifuga yunnanensis down-regulating the mRNA expression of CD147, MMP-2, and MMP-9. RSC Advances. 11(58). 36978–36988. 1 indexed citations
7.
Lu, Nihong, et al.. (2021). New cycloartane triterpenes from the roots of Cimicifuga foetida. Phytochemistry Letters. 42. 109–116. 2 indexed citations
8.
9.
Lu, Nihong, et al.. (2020). Sophoradiol inhibits the growth of drug resistant Mycobacterium tuberculosis in vitro and murine models of tuberculosis. Microbial Pathogenesis. 141. 103971–103971. 5 indexed citations
10.
Yang, Yanni, Wenlin Tai, Nihong Lu, et al.. (2020). lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging. 12(10). 9085–9102. 139 indexed citations
11.
12.
Yang, Zhao, Hui Zhan, Nihong Lu, et al.. (2019). <p>Clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis</p>. Cancer Management and Research. Volume 11. 4171–4184. 33 indexed citations
13.
Nian, Yin, Nihong Lu, Xiaoling Liu, et al.. (2018). Antiacetylcholinesterase triterpenes from the fruits of Cimicifuga yunnanensis. RSC Advances. 8(14). 7832–7838. 6 indexed citations
14.
Li, Yuanshi, Junxian Cao, Qianping Gao, et al.. (2018). MiR-130a inhibition protects rat cardiac myocytes from hypoxia-triggered apoptosis by targeting Smad4. Kardiologia Polska. 76(6). 993–1001. 17 indexed citations
15.
Yang, Lixia, et al.. (2018). Long noncoding RNA MALAT1 promotes high glucose-induced human endothelial cells pyroptosis by affecting NLRP3 expression through competitively binding miR-22. Biochemical and Biophysical Research Communications. 509(2). 359–366. 106 indexed citations
16.
Lu, Nihong, et al.. (2018). Omega‐6 fatty acids down‐regulate matrix metalloproteinase expression in a coronary heart disease‐induced rat model. International Journal of Experimental Pathology. 99(5). 210–217. 2 indexed citations
17.
18.
Zhang, Ziwei, Ruiwei Guo, Xianmei Wang, et al.. (2017). MicroRNA-99a inhibits insulin-induced proliferation, migration, dedifferentiation, and rapamycin resistance of vascular smooth muscle cells by inhibiting insulin-like growth factor-1 receptor and mammalian target of rapamycin. Biochemical and Biophysical Research Communications. 486(2). 414–422. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziqi Cheng Breakdown of academic impact, for papers by Xingruo Zeng Breakdown of academic impact, for papers by Hanqing Guo Breakdown of academic impact, for papers by Minyi Xu Breakdown of academic impact, for papers by Chen-Tsung Huang Breakdown of academic impact, for papers by Xiaopei Yan Breakdown of academic impact, for papers by Jiyuan Yang Breakdown of academic impact, for papers by Qing Ma Breakdown of academic impact, for papers by Zequn Niu Breakdown of academic impact, for papers by Yingjian Jiang
Rankless by CCL
2026